Buchumschlag

Meta-analysis of flecainide safety in patients with supraventricular arrhythmias

<p>Flecainide (CAS 54143-55-4) has been associated with increased mortality in patients with ventricular dysfunction and arrhythmias. It is a potent suppressant of supraventricular arrhythmias, but safety data for use in this condition are rare.</p> <p>A meta-analysis was performed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Wehling, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2002
In: Arzneimittelforschung
Year: 2002, Jahrgang: 52, Heft: 7, Pages: 507-514
ISSN:1616-7066
DOI:10.1055/s-0031-1299923
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0031-1299923
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0031-1299923
Volltext
Verfasserangaben:Martin Wehling

MARC

LEADER 00000caa a2200000 c 4500
001 1813977917
003 DE-627
005 20230710173545.0
007 cr uuu---uuuuu
008 220810s2002 xx |||||o 00| ||eng c
024 7 |a 10.1055/s-0031-1299923  |2 doi 
035 |a (DE-627)1813977917 
035 |a (DE-599)KXP1813977917 
035 |a (OCoLC)1389825662 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wehling, Martin  |d 1957-  |e VerfasserIn  |0 (DE-588)129939331  |0 (DE-627)484463152  |0 (DE-576)297912577  |4 aut 
245 1 0 |a Meta-analysis of flecainide safety in patients with supraventricular arrhythmias  |c Martin Wehling 
264 1 |c 2002 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Elektronische Reproduktion der Druck-Ausgabe 26. Dezember 2011 
500 |a Gesehen am 10.08.2022 
520 |a <p>Flecainide (CAS 54143-55-4) has been associated with increased mortality in patients with ventricular dysfunction and arrhythmias. It is a potent suppressant of supraventricular arrhythmias, but safety data for use in this condition are rare.</p> <p>A meta-analysis was performed including 122 prospective studies on the use of flecainide in patients with supraventricular arrhythmias and no significant signs of ventricular damage. 4811 patients on flecainide were included (mean age 55 ± 13 years, 60 % male). 38 studies were on i.v. Flecainide, 84 on p.o. application, 21 were placebo-controlled, 37 were comparative studies with other antiarrhythmics. The total exposure time was 2015 patient years, with a mean flecainide dose in p.o. studies of 216 ± 65 mg/day. The total database on flecainide contains the reports of 8 deaths (total mortality 0.166 %, mortality rate per 100 patient years 0.397). 3 deaths were non-cardiac deaths (cancer, suicide, urosepsis). Of the cardiac deaths, all but two occurred in patients with coronary heart disease. In controls, there was 1 death. Even for all deaths, this difference was not significant (p = 0.46). Proarrhythmic events were seen in 120 patients on flecainide, and, significantly more frequent, in 88 control patients (p < 0.001).</p> <p>The data clearly show that the use of flecainide in patients with supraventricular arrhythmias is safe and, because of its proven efficacy, advisable. Scrutiny should be exercised to diagnose all patients with structural left ventricular damage.</p> 
773 0 8 |i Enthalten in  |t Arzneimittelforschung  |d Stuttgart : Thieme, 1999  |g 52(2002), 7, Seite 507-514  |h Online-Ressource  |w (DE-627)324959478  |w (DE-600)2033167-8  |w (DE-576)30217771X  |x 1616-7066  |7 nnas  |a Meta-analysis of flecainide safety in patients with supraventricular arrhythmias 
773 1 8 |g volume:52  |g year:2002  |g number:7  |g pages:507-514  |g extent:8  |a Meta-analysis of flecainide safety in patients with supraventricular arrhythmias 
856 4 0 |u https://doi.org/10.1055/s-0031-1299923  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.thieme-connect.de/DOI/DOI?10.1055/s-0031-1299923  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220810 
993 |a Article 
994 |a 2002 
998 |g 129939331  |a Wehling, Martin  |m 129939331:Wehling, Martin  |d 60000  |d 65400  |e 60000PW129939331  |e 65400PW129939331  |k 0/60000/  |k 1/60000/65400/  |p 1  |x j  |y j 
999 |a KXP-PPN1813977917  |e 417789382X 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Meta-analysis of flecainide safety in patients with supraventricular arrhythmias","title_sort":"Meta-analysis of flecainide safety in patients with supraventricular arrhythmias"}],"person":[{"family":"Wehling","given":"Martin","roleDisplay":"VerfasserIn","display":"Wehling, Martin","role":"aut"}],"note":["Elektronische Reproduktion der Druck-Ausgabe 26. Dezember 2011","Gesehen am 10.08.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1813977917","origin":[{"dateIssuedDisp":"2002","dateIssuedKey":"2002"}],"id":{"doi":["10.1055/s-0031-1299923"],"eki":["1813977917"]},"name":{"displayForm":["Martin Wehling"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"title":[{"title_sort":"Arzneimittelforschung","title":"Arzneimittelforschung","subtitle":" = Drug research"}],"pubHistory":["Nachgewiesen 49.1999 - 62.2012"],"titleTranslated":[{"translated":"Drug research"}],"part":{"year":"2002","pages":"507-514","issue":"7","text":"52(2002), 7, Seite 507-514","volume":"52","extent":"8"},"titleAlt":[{"title":"ArzneimForsch"},{"title":"DrugRes"},{"title":"Arzneimittel-Forschung"}],"note":["Gesehen am 31.10.2013"],"disp":"Meta-analysis of flecainide safety in patients with supraventricular arrhythmiasArzneimittelforschung","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"324959478","language":["eng"],"origin":[{"publisher":"Thieme ; Editio-Cantor-Verl.","dateIssuedKey":"1999","dateIssuedDisp":"1999-2012","publisherPlace":"Stuttgart ; New York, NY ; Aulendorf"}],"id":{"issn":["1616-7066"],"eki":["324959478"],"doi":["10.1055/s-00000175"],"zdb":["2033167-8"]},"physDesc":[{"extent":"Online-Ressource"}]}]} 
SRT |a WEHLINGMARMETAANALYS2002 

Ähnliche Einträge